论文部分内容阅读
Aim: To investigate the combinatorial anti-tumorigenesis and anti-osteoclastogenesis effects of plumbagin and zoledronic acid on human breast cancer cells and cancer-induced activation of osteoclasts and the underlying mechanisms both in vitro and vivo.